The new facility serves as a one-stop location for drug treatment participants who previously had to visit multiple locations ...

IFx-2.0, an innate immune agonist, targets resistance to immune checkpoint inhibitors in advanced cutaneous melanoma, receiving FDA orphan drug designation. Phase 1 trials showed IFx-2.0's safety and ...

Trump administration details a new addiction initiative led by HHS secretary Kennedy emphasizing faith-based groups, tough ...

The Department of Health and Human Services (HHS) will invest $100 million to improve homelessness, opioid addiction and ...

Health Secretary Robert F. Kennedy Jr. on Monday announced that his department will devote $100 million toward a pilot ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced $100 million in new grants for homelessness and opioid ...

The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...

The FDA has granted orphan drug designation to IFx-2.0 for patients with stage 2B to stage 4 cutaneous melanoma. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the ...

Johnson returned to the Penn North Recovery Center to attend NA meetings, “This is where I got my foundation,” Johnson told The Sun. “I used that and my wife’s death to ...

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...

President Trump signed an executive order Thursday to coordinate a federal government response to drug addiction.